Briakinumab API Manufacturers

compare suppliers & get competitive offers

Sorry, there are currently no suppliers listed for this ingredient. Hopefully we can help you with other ingredients.

Want to be the first to find out when a supplier for Briakinumab is listed?

Join our notification list by following this page.

Are you a supplier of Briakinumab or other APIs and are you looking to list your company on Pharmaoffer?

Click the button below to find out more

LEARN MORE

Looking for a CDMO/CMO that can help you with your pharmaceutical needs?

Click the button below to switch over to the contract services area of Pharmaoffer.

LEARN MORE

Looking for Briakinumab API 339308-60-0?

Description:: Here you will find a list of producers, manufacturers and distributors of Briakinumab. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
API | Excipient name:: Briakinumab
Cas Number:: 339308-60-0
DrugBank number:: DB05459
Unique Ingredient Identifier:: 978I8M0P8X

About Briakinumab

Do you want to know more about Briakinumab? You can find a small explanation about it here. Briakinumab is a human anti-IL-12 monoclonal antibody being developed for the treatment of a number of T-cell driven autoimmune diseases. It targets and neutralize interleukin-12 and interleukin-23, two proteins associated with inflammation, such as pro-inflammatory interleukins or tumor necrosis factor- alpha. Briakinumab represents a novel approach to treating psoriasis, Multiple Sclerosis, Crohn’s Disease and other autoimmune and inflammatory disorders. As of 2011 drug development for psoriasis has been discontinued in the U.S. and Europe.

Ask the supplier for a certificate of analysis to find out more about the quality of Briakinumab.